Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of -13.04% and 12.76%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock ...
Ocular antibiotics are generally an extension of systemic antibiotics which are already tested for toxicity and tissue penetration efficacy. Most of the antibiotic development for systemic therapy ...
The future treatment of ocular infections may not be the development of new antibiotics, but the prevention of ocular infection by wise use of present antibiotics. Measures should be implemented ...